Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Egerer

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Arthritis and Rheumatism|June 28, 2006
Anti-20S proteasome autoantibodies inhibit proteasome stimulation by proteasome activator PA28Michael Brychcy, Ulrike Kuckelkorn, Gert Hausdorf, et al.
Arthritis Research & Therapy|June 24, 2010
Immediate determination of ACPA and rheumatoid factor--a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassayFranziska Renger, Holger Bang, Eugen Feist, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|August 11, 2004
Prevalence of 20S proteasome, anti-nuclear and thyroid antibodies in young patients at onset of type 1 diabetes mellitus and the risk of autoimmune thyroiditisOlga Kordonouri, Kathrin Meyer, Karl Egerer, et al.
The Journal of Rheumatology|October 11, 2002
Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseasesKarl Egerer, Ulrike Kuckelkorn, Paul E Rudolph, et al.
Arthritis and Rheumatism|August 1, 2007
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritisHolger Bang, Karl Egerer, Anke Gauliard, et al.
Arthritis Research & Therapy|February 12, 2011
Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosusFidan Barkhudarova, Cornelia Dähnrich, Anke Rosemann, et al.
Clinical and Experimental Rheumatology|September 6, 2014
Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patientsOlga Derganova, Lorena Martinez-Gamboa, Karl Egerer, et al.
Arthritis Research & Therapy|March 11, 2010
Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence testsKarl Egerer, Dirk Roggenbuck, Rico Hiemann, et al.
Arthritis Research & Therapy|July 23, 2011
Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assayKarl Egerer, Dirk Roggenbuck, Thomas Büttner, et al.
Arthritis and Rheumatism|April 29, 2006
Tissue-specific up-regulation of the proteasome subunit beta5i (LMP7) in Sjögren's syndromeThomas Egerer, Lorena Martinez-Gamboa, Anja Dankof, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Arthritis and Rheumatism|June 28, 2006
Anti-20S proteasome autoantibodies inhibit proteasome stimulation by proteasome activator PA28Michael Brychcy, Ulrike Kuckelkorn, Gert Hausdorf, et al.
Arthritis Research & Therapy|June 24, 2010
Immediate determination of ACPA and rheumatoid factor--a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassayFranziska Renger, Holger Bang, Eugen Feist, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|August 11, 2004
Prevalence of 20S proteasome, anti-nuclear and thyroid antibodies in young patients at onset of type 1 diabetes mellitus and the risk of autoimmune thyroiditisOlga Kordonouri, Kathrin Meyer, Karl Egerer, et al.
The Journal of Rheumatology|October 11, 2002
Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseasesKarl Egerer, Ulrike Kuckelkorn, Paul E Rudolph, et al.
Arthritis and Rheumatism|August 1, 2007
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritisHolger Bang, Karl Egerer, Anke Gauliard, et al.
Arthritis Research & Therapy|February 12, 2011
Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosusFidan Barkhudarova, Cornelia Dähnrich, Anke Rosemann, et al.
Clinical and Experimental Rheumatology|September 6, 2014
Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patientsOlga Derganova, Lorena Martinez-Gamboa, Karl Egerer, et al.
Arthritis Research & Therapy|March 11, 2010
Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence testsKarl Egerer, Dirk Roggenbuck, Rico Hiemann, et al.
Arthritis Research & Therapy|July 23, 2011
Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assayKarl Egerer, Dirk Roggenbuck, Thomas Büttner, et al.
Arthritis and Rheumatism|April 29, 2006
Tissue-specific up-regulation of the proteasome subunit beta5i (LMP7) in Sjögren's syndromeThomas Egerer, Lorena Martinez-Gamboa, Anja Dankof, et al.
Pageof 4